Comparison of 68Ga-FAPI PET/CT and 18F-FDG PET/CT in gastric cancer: impact on metastatic detection and stage migration
- 14 August 2026
- journal article
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 99 (1187) , 2406-2414
Abstract
Objectives: To compare the diagnostic performance of 18F-fluorodeoxyglucose (18F-FDG) PET/CT and ⁶⁸Ga-FAPI PET/CT in patients with gastric cancer, with particular emphasis on metastatic detection and stage migration. Methods: Fifty-two patients with histopathologically confirmed gastric cancer who underwent both 18F-FDG PET/CT and ⁶⁸Ga-FAPI PET/CT were retrospectively analyzed. Primary tumor uptake, metastatic involvement, and tumor staging were evaluated for each modality. Detection rates for lymph node, peritoneal, liver, and bone metastases were compared. Diagnostic performance and stage migration between modalities were assessed. Quantitative parameters including standardized uptake value and tumor-to-background ratio were analyzed. Results: ⁶⁸Ga-FAPI PET/CT demonstrated significantly higher uptake in primary tumors compared with 18F-FDG PET/CT (P < .001). Peritoneal metastases were detected in 30.8% (16/52) of patients on ⁶⁸Ga-FAPI PET/CT compared with 13.5% (7/52) on 18F-FDG PET/CT (P = .004). Nodal metastases were also identified more frequently with ⁶⁸Ga-FAPI PET/CT. Both modalities showed high diagnostic performance for liver metastases, while ⁶⁸Ga-FAPI PET/CT demonstrated slightly higher sensitivity for bone lesions and 18F-FDG PET/CT showed slightly higher specificity. Overall stage migration between the 2 modalities occurred in 25.0% (13/52) of patients, predominantly due to upstaging associated with newly detected metastatic disease. In subgroup analysis, 18F-FDG uptake tended to be lower in signet-ring cell carcinoma, whereas FAPI uptake appeared less influenced by histological subtype. Conclusion: : ⁶⁸Ga-FAPI PET/CT improves detection of metastatic disease, particularly peritoneal involvement, compared with 18F-FDG PET/CT in patients with gastric cancer and may contribute to more accurate disease staging. Advances in knowledge: This study highlights the added value of 68Ga-FAPI PET/CT in identifying metastatic disease and altering clinical staging, particularly through improved detection of peritoneal involvement, which may impact treatment decision-making.Keywords
This publication has 21 references indexed in Scilit:
- Comparative analysis of 68Ga-FAPI-46 PET/CT and 18F-FDG PET/CT in advanced epithelial ovarian cancer: implications for preoperative scoring and treatment planningEuropean Journal of Nuclear Medicine and Molecular Imaging, 2026
- The role of [⁶⁸Ga]Ga-FAP-2286 PET/CT in the evaluation of treatment response in gastrointestinal system malignanciesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2025
- Usefulness of [18F]FAPI-04 and [18F]FDG PET/CT for the Detection of Peritoneal Carcinomatosis: A Comparative StudyAcademic Radiology, 2025
- Head-to-head Comparison of [68Ga]Ga-FAPI-04 PET and [18F]FDG PET in the Evaluation of Primary Gastrointestinal Tumors and Metastases: A Systematic Review and Meta-analysisAcademic Radiology, 2025
- Head-to-head comparison of 68Ga-FT-FAPI with 68Ga-FAPI-04 in patients with gastrointestinal tumorsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2025
- [68Ga]Ga-FAPI-04 PET/MR imaging strategy in management of Krukenberg tumors (KTs) from gastric signet-ring-cell carcinoma: to overcome limitation of [68Ga]Ga-FAPI-04 PET imaging in KTsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2024
- FAPI-avid nonmalignant PET/CT findings: An expedited systematic reviewSeminars in Nuclear Medicine, 2023
- The potential utility of [68 Ga]Ga-DOTA-FAPI-04 as a novel broad-spectrum oncological and non-oncological imaging agent—comparison with [18F]FDGEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- Head-to-head comparison of [68Ga]Ga-FAPI-04 and [18F]-FDG PET/CT in evaluating the extent of disease in gastric adenocarcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findingsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003